May 11 (Reuters) - Valbiotis SA ALVAL.PA:
CREATION BY CHINESE JOINT VENTURE OF A SUBSIDIARY IN SINGAPORE
JV OWNED 49% BY VALBIOTIS AND 51% BY ITS PARTNER AIKA
COMMERCIAL LAUNCH IN CHINA IN SECOND HALF OF 2026
NEW SUBSIDIARY WILL GRADUALLY ADDRESS SEVERAL STRATEGIC MARKETS IN ASIA REGION, NOTABLY SINGAPORE, VIETNAM, INDONESIA AND JAPAN
DISTRIBUTION WILL BE HANDLED BY JOINT VENTURE'S HONG KONG SUBSIDIARY
Source text: ID:nEQ4w2zb1a
Further company coverage: ALVAL.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))